STD Risk Reduction for Heterosexual Methamphetamine Users
Substance-Related Disorders, HIV Infections, Sexually Transmitted Diseases
About this trial
This is an interventional prevention trial for Substance-Related Disorders focused on measuring HIV, STDs, Methamphetamine
Eligibility Criteria
Inclusion Criteria: HIV uninfected Use of methamphetamine via snorting or smoking at least once a month for the 2 months prior to study entry Heterosexual History of unprotected sex within 2 months prior to study entry Exclusion Criteria: Current diagnosis of a major psychiatric disorder with psychotic or suicidal symptoms History of consistent use of condoms or dental dams for oral, vaginal, or anal sex with all partners within 2 months prior to study entry Currently trying to get pregnant or get a partner pregnant
Sites / Locations
- HIV Neurobehavioral Research Center
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
1
2
Participants will receive the tri-focal cognitive behavioral therapy - social skills training counseling program
Participants will receive the standard care comparison condition